Search results for "Patient preference"

showing 10 items of 48 documents

Handling forces for the use of different inhaler devices.

2019

Abstract Age and comorbidities can impact on the success of handling an inhaler. In this pilot study, we assessed finger strength in 62 participants (aged 5–17 years [n = 20], 18–65 years [n = 22] and > 65 years [n = 20]) by using different types of inhalers with integrated sensors (Respimat®, Breezhaler®, Aerolizer®, Genuair®, Diskus®, Ellipta®, HandiHaler®, Turbohaler® and a pressurized metered-dose inhaler [Atrovent®]). Parameters under investigation included the spontaneous and maximum achievable force and torque required to operate devices. Satisfaction with individual inhalers, and the relationship between satisfaction and strength, were also assessed. There was a marked difference in…

AdultMalemedicine.medical_specialtyAdolescentPharmaceutical SciencePilot Projects02 engineering and technology030226 pharmacology & pharmacyFingers03 medical and health sciencesYoung Adult0302 clinical medicineAge groupsRheumatic DiseasesAdministration InhalationMedicineHumansChildAgedAged 80 and overHand Strengthbusiness.industryInhalerNebulizers and VaporizersHealthy subjectsAge FactorsRheumatic diseaseEquipment DesignMiddle Aged021001 nanoscience & nanotechnologyPatient preferenceDry-powder inhalerPatient SatisfactionCase-Control StudiesChild PreschoolPhysical therapyFemale0210 nano-technologybusinessInternational journal of pharmaceutics
researchProduct

A discrete-choice experiment to assess patients’ preferences for osteoarthritis treatment: An ESCEO working group

2020

Objective: To evaluate the preferences of patients with osteoarthritis for treatment.Methods: A discrete-choice experiment was conducted among adult OA patients who were presented with 12 choice sets of two treatment options and asked in each to select the treatment they would prefer. Based on literature reviews, expert consultation, patient survey and expert meeting, treatment options were characterized by seven attributes: improvement in pain, improvement in walking, ability to manage domestic activities, ability to manage social activities, improvement in overall energy and well-being, risk of moderate/severe side effects and impact on disease progression. Random parameters logit model w…

AdultMalemedicine.medical_specialtyDiscrete choice experimentOsteoarthritisOutcomes03 medical and health sciences0302 clinical medicinePHYSICIANSRheumatologySurveys and QuestionnairesOsteoarthritisMedicineHumans030212 general & internal medicineAgedOutcome030203 arthritis & rheumatologyddc:616HIPbusiness.industryDisease progressionDiscrete-choice experimentTreatment optionsPatient PreferencePatient preferencesmedicine.diseaseLatent class modelPreferenceEuropeInstitutional repositoryAnesthesiology and Pain MedicineLogistic ModelsPhysical therapyPatient surveyFemaleKNEEOsteoarthritiHEALTHbusiness
researchProduct

Individualizing Standardized Tests

2013

Author's version of an article in the journal: Qualitative Health Research. Also available from the publisher at: http://dx.doi.org/10.1177/1049732313499073 In assessing geriatric patients' functional status, health care professionals use a number of standardized tests. These tests have defined administration procedures that restrict communication and interaction with patients. In this article, we explore the experiences of occupational therapists and physiotherapists acting as standardized test administrators. Drawing on fieldwork, interviews with physiotherapists and occupational therapists, and observations of test situations on acute geriatric wards, we suggest that the test situation g…

AdultMalemedicine.medical_specialtyEvidence-based practiceinterviewsStandardizationIndividualityStandardized testSocial EnvironmentJudgmentYoung AdultOccupational TherapyNursingrelationship health careHealth careHumansMedicineGeriatric AssessmentCompetence (human resources)Physical Therapy Modalitieshealth care economics and organizationsAgedGeriatricsNorwaybusiness.industryCommunicationHealth carePublic Health Environmental and Occupational HealthPatient PreferenceProfessional-Patient RelationsEvidence-based practiceHealth care professionalsTest (assessment)HospitalizationObservational Studies as TopicGeriatricsrestrictVDP::Medisinske Fag: 700::Helsefag: 800::Sykepleievitenskap: 808FemaleRelationshipsOlder peoplebusinesshuman activitiesQualitative Health Research
researchProduct

An 18-Month Follow-up, Randomized Comparison of Effectiveness and Safety of Two Hyaluronic Acid Fillers for Treatment of Moderate Nasolabial Folds

2016

Hyaluronic acid (HA) filler injection is a popular nonsurgical aesthetic procedure.To compare the effectiveness and safety of 2 hyaluronic acid fillers (HAEC and HARES) for treatment of moderate nasolabial folds (NLFs).This was an evaluator- and subject-blinded split-face study. HAEC or HARES was randomly assigned to the left or right NLF at baseline. Retreatment was performed after 9 months; follow-up extended to 18 months after baseline (9 months after retreatment). Effectiveness assessments included the Wrinkle Severity Rating Scale (WSRS) and subject preference. Safety assessments included adverse events (AEs) and local tolerability symptoms recorded by subjects during 3 weeks after tre…

AdultMalemedicine.medical_specialtyNasolabial FoldTime FactorsTreatment outcomeDermatology030230 surgerylaw.invention030207 dermatology & venereal diseases03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDouble-Blind MethodRandomized controlled triallawDermal FillersHyaluronic acidmedicineHumansHyaluronic AcidAgedbusiness.industryFollow up studiesPatient PreferenceGeneral MedicineMiddle AgedNasolabial foldPatient preferenceSkin AgingSurgeryTreatment Outcomemedicine.anatomical_structureMulticenter studychemistryRetreatmentFemaleSurgerybusinessFollow-Up StudiesMonth follow upDermatologic Surgery
researchProduct

Characteristics and determinants of patient burden and needs in the treatment of chronic spontaneous urticaria

2019

Objectives: Treatment of chronic spontaneous urticaria (CSU) is based on evidence-based guidelines. However, specific patient needs and benefits from therapy have not been differentiated on the guideline level. The current study was designed to use the first part of the PBI, the PNQ, to characterize[for full text, please go to the a.m. URL]

AdultMalemedicine.medical_specialtyTime FactorsCross-sectional studyHealth StatusDermatologyDiseasePatient Care Planning030207 dermatology & venereal diseases03 medical and health sciencesSex Factors0302 clinical medicineCost of IllnessQuality of lifeSurveys and QuestionnairesInternal medicinemedicineHumansChronic UrticariaDisease burdenChronic urticariaAgedbusiness.industryPruritusPatient PreferenceGuidelineMiddle Aged610 Medical sciences; MedicineCross-Sectional StudiesPatient burden030228 respiratory systemddc: 610Quality of LifeItchingFemalemedicine.symptombusinessDecision Making SharedNeeds Assessment
researchProduct

Defer or treat? Reasons for treatment decisions in patients with chronic hepatitis C genotype 1 in the early era of directly acting antiviral agents

2013

Abstract Background In chronic genotype 1 hepatitis C, telaprevir or boceprevir plus peginterferon and ribavirin have become the new standard of care. Aim of this study was to identify factors contributing to the decision whether to defer or treat with the current triple regimens. Methods Prospective assessment of eight parameters on 0-4-point scales by the attending physician at a German tertiary referral centre between 1st September 2011 and 31st December 2012. Results 307 patients were evaluated at least once by one of the 11 hepatologists involved; 267 patients were considered, but only 163 were recommended to receive triple therapy. Multivariate regression analysis revealed that a high…

AdultMalemedicine.medical_specialtyTime FactorsProlineDecision MakingHepacivirusPharmacologyAntiviral AgentsSeverity of Illness IndexPolyethylene GlycolsTelaprevirCohort Studieschemistry.chemical_compoundFibrosisBoceprevirInternal medicineDrug DiscoveryRibavirinGenotypemedicineHumansDecompensationProspective StudiesWatchful WaitingAgedDrug CarriersHepatologybusiness.industryRibavirinGastroenterologyInterferon-alphaPatient PreferenceHepatitis CHepatitis C ChronicMiddle Agedmedicine.diseaseLogistic ModelschemistryTolerabilityMultivariate AnalysisDisease ProgressionDrug Therapy CombinationFemalebusinessOligopeptidesmedicine.drugDigestive and Liver Disease
researchProduct

Assessing Preferences in Patients with Head and Neck Squamous Cell Carcinoma: Phase I and II of Questionnaire Development.

2020

Shared-decision making for head and neck squamous cell carcinoma (HNSCC) is challenged by the difficulty to integrate the patient perception of value within the framework of a multidisciplinary team approach. The aim of this study was to develop a questionnaire to assess the preferences of HNSCC patients with respect to the disease trajectory, expected treatment, and toxicities. In accordance with the standardized EORTC Quality of Life Group&rsquo

Cancer Researchmedicine.medical_specialtyScoring criteriaDiseaselcsh:RC254-282Article03 medical and health sciences0302 clinical medicineQuality of lifehead and neck cancer; multimodal therapies; patient preferences; patient priorities; quality of lifeHealth caremedicineIn patient030212 general & internal medicinemultimodal therapiesneoplasmsbusiness.industryHead and neck cancermedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensHead and neck squamous-cell carcinoma3. Good healthstomatognathic diseasesPatient perceptionsOncologypatient prioritiesquality of life030220 oncology & carcinogenesisFamily medicinehead and neck cancerbusinesspatient preferences
researchProduct

Clinical Practice Guideline on Melanoma From the Spanish Academy of Dermatology and Venereology (AEDV)

2020

El diagnóstico y tratamiento del melanoma en atención especializada es un campo en el que se han producido numerosos cambios. El objetivo de esta guía es ofrecer a los dermatólogos españoles una referencia para resolver las dudas clínicas más frecuentes basándose en la evidencia actual. Para la realización de esta guía se escogió a miembros del Grupo Español de Dermato-Oncología y Cirugía con experiencia en el tratamiento de estos tumores y con interés en participar en la elaboración de la guía. Se hizo una adaptación de las guías de práctica clínica existentes mediante el método ADAPTE: inicialmente se resumió el proceso de atención y se elaboraron las preguntas clínicas relevantes. Se sel…

Care processmedicine.medical_specialtyPractice guidelineHistologyVenereologySkin NeoplasmsBiopsyTerapéuticaAntineoplastic AgentsDermatologyTherapeutics030204 cardiovascular system & hematologyPathology and Forensic MedicineHutchinson's Melanotic Freckle03 medical and health sciences0302 clinical medicineDiagnòsticDiagnosismedicineRelevance (law)HumansAgree ii030212 general & internal medicineNeoplasm MetastasisMelanomaNeoplasm StagingEvidence-Based Medicinebusiness.industrySentinel Lymph Node BiopsyDiagnósticoDisease ManagementGuidelineDiagnosis Diagnóstico Guía de práctica clínica Melanoma Practice guideline Terapéutica TherapeuticsTerapèuticaPatient preferenceDermatologyCombined Modality TherapyClinical PracticeGuía de práctica clínicaMolecular Diagnostic Techniquesbusiness
researchProduct

Nutraceuticals and dyslipidaemia: Beyond the common therapeutics

2014

Dyslipidaemia accelerates the atherosclerotic process and its morbid consequences; statins represent the evidence-based treatment of choice for reducing low-density lipoprotein cholesterol levels and decreasing cardiovascular events. Unfortunately, statins are frequently not available for several reasons, including intolerance, side effects or, simply, patient preference. Nutraceuticals and functional food ingredients that are beneficial to vascular health may represent useful compounds that are able to reduce the overall cardiovascular risk induced by dyslipidaemia by acting parallel to statins or as adjuvants in case of failure or in situations where statins cannot be used. The mechanisms…

DyslipidaemiaMedicine (miscellaneous)Pharmacologychemistry.chemical_compoundPharmacotherapyNutraceuticalFunctional foodMedicineTX341-641Nutrition and DieteticsCholesterolbusiness.industryNutrition. Foods and food supplyStatinsnutritional and metabolic diseasesPatient preferenceCardiovascular diseaseschemistryMrna levelnutrizione; Nutraceuticallipids (amino acids peptides and proteins)NutraceuticalsDrug therapyFaecal excretionbusinessFood ScienceLipoprotein
researchProduct

AGO Algorithms for the Treatment of Breast Cancer: Update 2021

2021

Geburtshilfe und Frauenheilkunde 81(10), 1101-1111 (2021). doi:10.1055/a-1519-7089

Evidence-based practicePerformance statusbusiness.industryObstetrics and GynecologyTreatment optionsRecommendationmedicine.diseasetherapy algorithmsPatient preferenceMetastatic breast cancerevidence-based treatmentBreast cancerevidenzbasierte TherapieMaternity and Midwiferybreast cancer guidelinesmedicineTreatment decision makingGebFra ScienceBehandlungsalgorithmenbusinessAlgorithmBrustkrebs-Leitlinien
researchProduct